Merck Annual Report 2007

Share data¹

1	Share-price relevant figures relate to the closing price in Xetra ® trading on the Frankfurt Stock Exchange.
2	The calculation of the theoretical number of shares is based on the fact that the general partner‘s equity capital is not represented by shares. As the share capital of € 168.0 million was divided into 64.6 million shares, the corresponding calculation for the general partner‘s capital of € 397.2 million resulted in 152.8 million theoretical shares on December 31, 2007. The number of shares increased due to the capital increase in January 2007.
3	For details, see Consolidated Financial Statements.
4	Based on the theoretical number of shares

2007

2006

Earnings per share after tax and minority interest from continuing operations (in €)

–0.50

4.06

Earnings per share after tax and minority interest from continuing and discontinued operations (in €)

16.21

5.07

Dividend in €

1.20

0.90

One-time bonus in €

2.00

0.15

Share price high in € (June 15, 2007)

106.55

89.10

Share price low in € (January 2, 2007)

79.96

63.96

Year-end share price (Dec. 28, 2007)

88.30

78.54

Price-earnings ratio (Dec. 28, 2007)

5.45

15.49

Actual number of shares in millions (Dec. 28, 2007)

64.6

51.3

Theoretical total number² of shares in millions (Dec. 28, 2007)

217.4

191.0

Adjusted weighted average number of theoretical shares outstanding³ (in millions)

215.9

194.0

Market capitalization⁴ in € million (Dec. 28, 2007)

19,196

15,001

Share data Audited by KPMG